# Furosemide vs. Placebo for Severe Antepartum Hypertension

> **NCT04615624** · PHASE3 · COMPLETED · sponsor: **Melanie Maykin, MD** · enrollment: 65 (actual)

## Conditions studied

- Pre-Eclampsia
- Hypertension in Pregnancy
- Pregnancy Complications
- Hypertension, Pregnancy-Induced

## Interventions

- **DRUG:** Furosemide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04615624
- **Lead sponsor:** Melanie Maykin, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-04
- **Primary completion:** 2022-04-22
- **Final completion:** 2022-04-29
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04615624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04615624, "Furosemide vs. Placebo for Severe Antepartum Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04615624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*